Financhill
Back

Catalyst Pharmaceuticals Vs. Edgewise Therapeutics Industry Stock Comparison

Sell
44

CPRX
Catalyst Pharmaceuticals

Last Price:
19.60
Seasonality Move:
-6.64%
Sell
28

EWTX
Edgewise Therapeutics

Last Price:
17.54
Seasonality Move:
-10.59%
Sell
44
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $19.59. The Score for CPRX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Edgewise Therapeutics (EWTX) is a Sell

Is Edgewise Therapeutics a Buy, Sell or Hold?

  • The current Edgewise Therapeutics [EWTX] share price is $17.55. The Score for EWTX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • EWTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $19.59
    The current trend is moderately bullish and CPRX is experiencing slight selling pressure.

EWTX Stock Price Chart

What is Edgewise Therapeutics's stock price today?

  • The Edgewise Therapeutics share price today is $17.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.59 Buy
Relative Strength Index (14 RSI): 54.22 Buy
Chaikin Money Flow: -34804 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.76 - 20.8) Buy
Bollinger Bands (100): (14.95 - 18.53) Buy

EWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 43.56 Sell
Chaikin Money Flow: 589776 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.59 - 19.45) Sell
Bollinger Bands (100): (16.43 - 20.15) Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.02 Sell
20-day SMA: 19.96 Sell
50-day SMA: 17.88 Buy
200-day SMA: 15.88 Buy
8-day EMA: 19.91 Sell
20-day EMA: 19.57 Buy
50-day EMA: 18.35 Buy
200-day EMA: 16.2 Buy

EWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.33 Sell
20-day SMA: 18.51 Sell
50-day SMA: 19.03 Sell
200-day SMA: 15.99 Buy
8-day EMA: 18.17 Sell
20-day EMA: 18.43 Sell
50-day EMA: 18.49 Sell
200-day EMA: 16.08 Buy

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.

Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.09 per share, an increase this year of $0.05 per share, and a decrease next year of $0.36 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Edgewise Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):